Provided by Tiger Trade Technology Pte. Ltd.

PRF Technologies Ltd.

1.01
+0.110012.22%
Post-market: 0.9544-0.0556-5.50%17:05 EDT
Volume:6.05M
Turnover:6.69M
Market Cap:3.53M
PE:-0.20
High:1.27
Open:0.9110
Low:0.9108
Close:0.9000
52wk High:7.95
52wk Low:0.8519
Shares:3.50M
Float Shares:3.04M
Volume Ratio:107.88
T/O Rate:198.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0000
EPS(LYR):-7.4664
ROE:-45.33%
ROA:-21.87%
PB:0.22
PE(LYR):-0.14

Loading ...

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:51 PM

Reuters
·
Jun 16

Consumer Tech News (May 25-29): Dell, IBM, CrowdStrike, Meta Lead Big Tech AI Push

Benzinga Earnings
·
May 31

Why Is Penny Stock PRF Technologies (PRFX) Up Today?

TIPRANKS
·
May 29

Top Premarket Gainers

MT Newswires Live
·
May 29

PRF Technologies announces results from study comparing PRF-110 to Zynrelef

TIPRANKS
·
May 26

PRF Technologies says PRF-110 matches Zynrelef in 72-hour pig post-surgery pain study

Reuters
·
May 26

Prf Technologies Announces Prf-110 Demonstrated Sustained 72-Hour Analgesic Activity Comparable to Approved, Commercially Available Benchmark in Head-to-Head Preclinical Study

THOMSON REUTERS
·
May 26

Prf Technologies Ltd - Prf-110 Achieves Sustained Analgesia With Ropivacaine-Only, Nsaid-Free Formulation

THOMSON REUTERS
·
May 26

Prf Technologies Ltd - Prf-110 Shows Consistent Safety and Tolerability in Preclinical Pig Study

THOMSON REUTERS
·
May 26

PRF Technologies sells 24,384 unregistered shares to Yorkville for fees

Reuters
·
May 08

PRF Technologies announces FDA clearance of OcuRing-K NDA

TIPRANKS
·
Apr 28

PRF wins FDA IND clearance for OcuRing-K Phase II cataract trial

Reuters
·
Apr 28

Prf Technologies Ltd - to Initiate Phase Ii Trial in U.S. With Enrollment Expected in H2 2026

THOMSON REUTERS
·
Apr 28

Prf Technologies Announces FDA Clearance of Ind Application for Ocuring™-K Phase Ii Clinical Trial

THOMSON REUTERS
·
Apr 28

What's Going On With Pharma Company PRF Technologies On Tuesday?

Benzinga Earnings
·
Apr 07

Top Premarket Gainers

MT Newswires Live
·
Apr 06

Israeli drug delivery firm PainReform's 2025 net loss narrows on reduced R&D expenses

Reuters
·
Mar 27

PRF Technologies In FY25 Had ~$4.1M In Cash, Cash Equivalents, Short-Term Deposits And Restricted Cash And Positive Working Capital Of ~$1.9M

Benzinga Earnings
·
Mar 27

Prf Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across Healthcare and AI-Driven Solar Platforms

THOMSON REUTERS
·
Mar 27

PainReform Ltd FY Net Income USD -4.8 Million

THOMSON REUTERS
·
Mar 27